Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    The AML Sessions: emerging immunotherapies, venetoclax-based regimens and targeted therapies in AML

    The AML Sessions: emerging immunotherapies, venetoclax-based regimens and targeted therapies in AML

    FromVJHemOnc Podcast

    Start listeningView podcast show

    The AML Sessions: emerging immunotherapies, venetoclax-based regimens and targeted therapies in AML

    FromVJHemOnc Podcast

    ratings:
    Length:
    53 minutes
    Released:
    Jul 16, 2020
    Format:
    Podcast episode

    Description

    The acute myeloid leukemia (AML) field has witnessed rapid evolution of late, with exciting developments in strategies for the treatment...
    The post The AML Sessions: emerging immunotherapies, venetoclax-based regimens and targeted therapies in AML appeared first on VJHemOnc.
    Released:
    Jul 16, 2020
    Format:
    Podcast episode

    Titles in the series (100)

    The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com